tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL

Compare AbCellera Biologics (ABCL) vs. Competitors

Compare
2,273 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
AbCellera Biologics
$3.50
$1.08B
-6.07
10.41%
4 Buy
1 Hold
0 Sell
Strong Buy
Syndax Pharmaceuticals
$21.35
$1.77B
-5.91
50.67%
10 Buy
0 Hold
0 Sell
Strong Buy
Arcus Biosciences
$21.66
$2.60B
-6.31
67.91%
5 Buy
2 Hold
0 Sell
Moderate Buy
Dianthus Therapeutics
$53.18
$2.29B
-15.23
140.09%
9 Buy
0 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$28.89
$2.98B
-18.32
3.10%
8 Buy
1 Hold
0 Sell
Strong Buy
Structure Therapeutics, Inc. Sponsored ADR
$88.45
$5.37B
-24.60
199.77%
15 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ABCL
AbCellera Biologics
3.50
0.29
9.03%
SNDX
Syndax Pharmaceuticals
21.35
6.94
48.16%
RCUS
Arcus Biosciences
21.66
8.25
61.52%
DNTH
Dianthus Therapeutics
53.18
30.89
138.58%
EWTX
Edgewise Therapeutics
28.89
-0.61
-2.07%
GPCR
Structure Therapeutics, Inc. Sponsored ADR
89.84
59.89
199.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts